Ara 290 and Thymosin Beta-4 Interaction
Ara 290 and Thymosin Beta-4 have a compatible interaction with 90% confidence. No known interactions; different mechanisms for tissue protection. Both compounds affect the blood vessels, so monitoring these systems is recommended.
Compound Profiles
Ara 290
Tissue-Protective Peptide | Innate Repair Receptor Agonist
Activates IRR through EPOR/β-common receptor complex, triggering tissue-protective signaling without erythropoietic effects..
View full profileThymosin Beta-4
43-Amino Acid Regenerative Peptide | Tissue Repair & Healing
Direct systemic delivery provides optimal bioavailability and distribution to target tissues for comprehensive regenerative effects including angiogenesis, cell migration, and differentiation..
View full profileCombined Organ Load
Frequently Asked Questions
Can I take Ara 290 with Thymosin Beta-4?
Yes, Ara 290 and Thymosin Beta-4 can generally be taken together. No known interactions; different mechanisms for tissue protection.
Is Ara 290 and Thymosin Beta-4 safe together?
Based on documented research, this combination is considered compatible. No critical safety flags identified for this pair.
What are the interactions between Ara 290 and Thymosin Beta-4?
No known interactions; different mechanisms for tissue protection. This assessment has 90% confidence and is based on documented research data.
How should I time Ara 290 and Thymosin Beta-4?
Ara 290 has a half-life of ~20 minutes (SubQ), ~2 minutes (IV) and Thymosin Beta-4 has a half-life of Dose-dependent; relatively short (exact values not established). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.